South Korea Cytokine Release Assays Market was valued at USD 0.1 Billion in 2022 and is projected to reach USD 0.3 Billion by 2030, growing at a CAGR of 10.5% from 2024 to 2030.
The South Korea Cytokine Release Assays (CRA) market is witnessing substantial growth, driven by increasing demand from pharmaceutical companies, academic research institutions, and the biotechnology sector. Cytokine release assays are crucial tools for testing the immunogenicity of biological products, especially in the context of monoclonal antibody therapies and CAR-T cell therapies. These assays play a pivotal role in detecting and quantifying the release of cytokines, which is essential in evaluating the safety and efficacy of therapeutic treatments. In South Korea, the rise in clinical trials and biopharmaceutical innovations is significantly boosting the demand for these assays.
Industries are increasingly adopting Cytokine Release Assays for their ability to provide reliable data on immune responses, particularly in drug development processes. This is especially critical for ensuring that therapies do not trigger harmful cytokine storms, a dangerous overreaction of the immune system that can occur during treatments like immunotherapies. The South Korean market sees substantial engagement from pharmaceutical giants, as well as biotech startups looking to incorporate advanced immunology into their product pipelines.
The key market drivers in South Korea are the advancements in immunotherapy, particularly CAR-T cell therapies, and the growing demand for personalized medicine. Companies are focusing on enhancing the accuracy of CRA to detect immune responses, which helps in minimizing adverse effects and improving treatment outcomes. This demand is also fuelled by government initiatives to boost biotechnology research and development in South Korea. Additionally, the increasing number of collaborations between local pharmaceutical firms and global biotech companies further propels the market's growth.
In terms of market segmentation, South Korea's CRA market is categorized based on product types such as enzyme-linked immunosorbent assays (ELISA), flow cytometry-based assays, and other emerging technologies. The choice of assay type largely depends on the application, with flow cytometry being particularly favored for high-throughput analysis, while ELISA remains a reliable method for specific cytokine detection. As the industry continues to evolve, the demand for more sophisticated testing methods is expected to increase, ensuring that the Cytokine Release Assays market in South Korea will remain pivotal in supporting the country’s biopharma sector.
The growing need for highly accurate and effective testing methods, along with the rapid expansion of biopharmaceutical industries, ensures that the Cytokine Release Assays market in South Korea will continue to evolve. As the demand for safe and effective immunotherapies rises, these assays will play an increasingly critical role in shaping the future of healthcare and drug development in the country.
Get an In-Depth Research Analysis of the South Korea Cytokine Release Assays Market Size And Forecast [2025-2032]
Â
iQ Biosciences
Antibody Analytics Ltd.
Immundnz
Pacific BioLabs
Celentyx Ltd
ProImmune Ltd.
Creative Biolabs
Pestka Biomedical Laboratories
Inc.
Shanghai ChemPartner
Bio-Techne
Abzena Ltd
ProMab
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Cytokine Release Assays Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Cytokine Release Assays Market
Flow Cytometry-Based Assays
ELISA (Enzyme-Linked Immunosorbent Assay)
Luminex xMAP Technology
Bioassays
Real-Time Quantitative PCR (qPCR)
Drug Development
Clinical Diagnostics
Immuno-oncology Research
Vaccine Development
Autoimmune Disease Research
Pharmaceutical Companies
Biotechnology Firms
Academic & Research Institutions
Contract Research Organizations (CROs)
Clinical Laboratories
Cytometry
Mass Spectrometry
Protein Microarrays
Cell-Based Assays
Nanoparticle-Based Technologies
North America
Europe
Asia-Pacific
Latin America
The Middle East & Africa
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Cytokine Release Assays Market Research Analysis
1. Introduction of the South Korea Cytokine Release Assays Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Cytokine Release Assays Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Cytokine Release Assays Market, By Type
6. South Korea Cytokine Release Assays Market, By Application
7. South Korea Cytokine Release Assays Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Cytokine Release Assays Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/